90 related articles for article (PubMed ID: 23517900)
21. FDA approves generic enoxaparin.
Voelker R
JAMA; 2010 Aug; 304(8):844. PubMed ID: 20736461
[No Abstract] [Full Text] [Related]
22. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
Grims RH; Weger W; Reiter H; Arbab E; Kränke B; Aberer W
Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
[TBL] [Abstract][Full Text] [Related]
23. Fat necrosis associated with the subcutaneous injection of enoxaparin.
Davies J; Lagattolla NR; Scholey G
Postgrad Med J; 2001 Jan; 77(903):43-4. PubMed ID: 11123395
[No Abstract] [Full Text] [Related]
24. [Hemorrhage after accidental overdosage of enoxaparin: monitoring and therapy].
Weber CF; Meybohm P; Kramer S; Linke R; Risteski P; Moritz A; Zacharowski K; Stein P; Miesbach W
Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Jun; 49(6):368-73. PubMed ID: 25004380
[TBL] [Abstract][Full Text] [Related]
25. Regarding "Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patients".
Paramo JC; Sendzischew H; Sivina M
J Vasc Surg; 2003 Mar; 37(3):700-1; author reply 701. PubMed ID: 12618719
[No Abstract] [Full Text] [Related]
26. An open label, non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers.
Gomes M; Ramacciotti E; Hoppensteadt D; Walenga JM; Lewis B; Thethi I; Fareed J
Clin Appl Thromb Hemost; 2011 Feb; 17(1):66-9. PubMed ID: 21220365
[TBL] [Abstract][Full Text] [Related]
27. [The impact of thromboprophylaxis with enoxaparin on bleeding rate in rejuvenating facelift procedures].
Kuz'min VV; Buzov DA; Nudel'man SV; Golubkov NA
Khirurgiia (Mosk); 2014; (7):66-71. PubMed ID: 25146545
[TBL] [Abstract][Full Text] [Related]
28. Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes.
Collet JP; Montalescot G; Golmard JL; Tanguy ML; Ankri A; Choussat R; Beygui F; Drobinski G; Vignolles N; Thomas D
Am Heart J; 2004 Apr; 147(4):655-61. PubMed ID: 15077081
[TBL] [Abstract][Full Text] [Related]
29. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
[TBL] [Abstract][Full Text] [Related]
30. Low-molecular-weight heparin-associated fat necrosis of the breast.
Das AK
Age Ageing; 2005 Mar; 34(2):193-4. PubMed ID: 15713870
[TBL] [Abstract][Full Text] [Related]
31. Enoxaparin sodium-induced bullous pemphigoid-like eruption: a report of 2 cases.
Dyson SW; Lin C; Jaworsky C
J Am Acad Dermatol; 2004 Jul; 51(1):141-2. PubMed ID: 15243541
[No Abstract] [Full Text] [Related]
32. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
33. Delayed Allergic Reaction to Acenocoumarol With a Positive Lymphocyte Transformation Test.
Dominguez-Ortega J; Entrala A; Pola-Bibian B; Gonzalez-Muñoz M; Fiandor A; Quirce S
J Investig Allergol Clin Immunol; 2016; 26(4):273-4. PubMed ID: 27470649
[No Abstract] [Full Text] [Related]
34. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
Lassen MR; Gallus A; Raskob GE; Pineo G; Chen D; Ramirez LM;
N Engl J Med; 2010 Dec; 363(26):2487-98. PubMed ID: 21175312
[TBL] [Abstract][Full Text] [Related]
35. [Hypersensitivity reaction to enoxaparine].
Romero Ortega MR; Luque Sánchez M
Aten Primaria; 2000 Apr; 25(7):521-2. PubMed ID: 10851763
[No Abstract] [Full Text] [Related]
36. Spinal epidural hematoma following central neuraxial blockade and subcutaneous enoxaparin: a case report.
Chan L; Bailin MT
J Clin Anesth; 2004 Aug; 16(5):382-5. PubMed ID: 15374561
[TBL] [Abstract][Full Text] [Related]
37. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Cohen AT; Spiro TE; Büller HR; Haskell L; Hu D; Hull R; Mebazaa A; Merli G; Schellong S; Spyropoulos AC; Tapson V;
N Engl J Med; 2013 Feb; 368(6):513-23. PubMed ID: 23388003
[TBL] [Abstract][Full Text] [Related]
38. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
[TBL] [Abstract][Full Text] [Related]
39. Recurrent Anaphylaxis Due to Enoxaparin.
Leguísamo S; Prados Castaño M; Piñero Saavedra M; Cimbollek S
J Investig Allergol Clin Immunol; 2015; 25(4):297-9. PubMed ID: 26310046
[No Abstract] [Full Text] [Related]
40. Throbbing headache associated with enoxaparin administration: a case report, a review of pharmacovigilance databases for similar cases and possible mechanisms.
Brusadelli T; Carnovale C; Gentili M; Borsadoli C; Speziali A; Perrone V; Pellegrino P; Antoniazzi S; Pozzi M; Radice S; Clementi E
J Clin Pharm Ther; 2015 Jun; 40(3):342-4. PubMed ID: 25726970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
